To verify the reliability and accuracy of our diagnostic model, we performed several experiments and demonstrated that depletion of MSH2 significantly suppressed proliferation, and weakened the migration and invasion ability of GBM cells, indicating that MSH2 is a prognostic and therapeutic target for GBM. The gene discussed is MSH2; the disease is glioblastoma.